U.S. Retinal Therapeutics Market
U.S. Retinal Therapeutics Market
07-Jun-2011
North America
$4,950.00
Special Price $3,712.50 save 25 %
Description
This research service provides an indepth analysis of factors affecting the growth of the U.S. retinal therapeutics market over the period 2006-2016. Included are disease and treatment overviews, product analyses, patient forecasts, product revenue forecasts, and market share analyses. In this research service, the market is segmented by retinal disease: age-related macular degeneration (AMD), diabetic retinopathy (DR)/diabetic macular edema (DME), and both branch and central retinal vein occlusion (BRVO/CRVO). Major market challenges, drivers, and restraints are identified and discussed. Additionally, a pipeline of compounds making their way through clinical trials is presented in the "Product Pipeline" section of this research service.
Table of Contents
U.S. Retinal Therapeutics Market
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Introduction
- Disease Overviews
Clinical Need and Burden of Disease
- Age-related Macular Degeneration
- Diabetic Retinopathy and Diabetic Macular Edema
- Retinal Vein Occlusion
Market Trends
- Market Engineering Measurements
- Industry Challenges and Strategies
- Market Drivers
Treatment Overview
Product Pipeline
Market Outlook and Revenue Forecasts
Competitive Overview
Decision Support Databases
Popular Topics
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N85D-01-00-00-00 |
Is Prebook | No |